Net Cash Provided by (Used in) Operating Activities |
407M |
USD |
+3.9% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-118M |
USD |
-402% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-265M |
USD |
+35% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
270M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
97.6M |
shares |
-2.57% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
24.6M |
USD |
+1.52% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
25.9M |
USD |
+232% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
41.9M |
USD |
+16.4% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
1.81M |
USD |
-3.99% |
Q4 2024 |
FY 2024 |
Property, Plant and Equipment, Gross |
10.9B |
USD |
+19% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
46.6M |
USD |
+1590% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
117M |
USD |
-19.9% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Current Income Tax Expense (Benefit) |
2.8M |
USD |
+300% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
2.12B |
USD |
+21.7% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Interest Expense |
143M |
USD |
+55.1% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2024 |
Q3 2024 |